These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

916 related articles for article (PubMed ID: 9602057)

  • 1. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
    Mellon RD; Bayer BM
    Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
    J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation.
    Nelson CJ; Schneider GM; Lysle DT
    Brain Behav Immun; 2000 Sep; 14(3):170-84. PubMed ID: 10970678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
    Stewart PE; Hammond DL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption.
    White DA; Ballard ME; Harmon AC; Holtzman SG
    Brain Res Bull; 2008 Aug; 76(6):597-604. PubMed ID: 18598850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
    Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
    Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
    Schmidt BL; Tambeli CH; Levine JD; Gear RW
    Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat.
    Wang XM; Yan JQ; Zhang KM; Mokha SS
    Brain Res; 1996 Nov; 739(1-2):235-43. PubMed ID: 8955943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of central mu-opioid receptors in the modulation of nitric oxide production by splenocytes.
    Schneider GM; Lysle DT
    J Neuroimmunol; 1998 Aug; 89(1-2):150-9. PubMed ID: 9726837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine.
    Calcagnetti DJ; Holtzman SG
    Pharmacol Biochem Behav; 1991 Jan; 38(1):185-90. PubMed ID: 2017444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats.
    Omote K; Kitahata LM; Nakatani K; Collins JG
    Brain Res; 1991 Jul; 554(1-2):299-303. PubMed ID: 1657291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioidergic modulation of ethanol self-administration in the ventral pallidum.
    Kemppainen H; Raivio N; Suo-Yrjo V; Kiianmaa K
    Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mu, delta and kappa opioid antagonists on the depression of a C-fiber reflex by intrathecal morphine and DAGO in the rat.
    Guirimand F; Strimbu-Gozariu M; Willer JC; Le Bars D
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1007-20. PubMed ID: 7912273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
    Stoller DC; Sim-Selley LJ; Smith FL
    Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.